sinc
immunohistochemistri
ihc
dramat
transform
approach
histopatholog
diagnosi
specif
diagnosi
classif
tumor
recent
diagnosi
infecti
diseas
tissu
sampl
pathologist
play
import
role
recogn
infecti
agent
tissu
sampl
patient
provid
rapid
morpholog
diagnosi
facilit
clinic
decis
patient
treatment
fresh
tissu
avail
cultur
pathologist
provid
rapid
morpholog
diagnosi
facilit
clinic
decis
patient
treatment
addit
pathologist
play
central
role
identifi
emerg
reemerg
infecti
agent
describ
pathogenet
process
emerg
diseas
eg
hantaviru
pulmonari
syndrom
viral
hemorrhag
fever
leptospirosi
rickettsi
ehrlichi
infect
diagnos
anthrax
bioterrorist
attack
cultur
serolog
assay
usual
use
microbi
identif
infecti
diseas
howev
fresh
tissu
alway
avail
cultur
fastidi
pathogen
difficult
may
take
week
month
yield
result
moreov
cultur
alon
distinguish
colon
tissu
invas
addit
serolog
result
difficult
interpret
set
immunosuppress
singl
sampl
avail
evalu
microorgan
distinct
morpholog
characterist
allow
identif
formalinfix
tissu
use
routin
special
stain
nevertheless
mani
instanc
difficult
even
imposs
identifi
infecti
agent
specif
convent
morpholog
method
immunohistochemistri
one
power
techniqu
surgic
patholog
increas
interest
use
specif
antibodi
viral
bacteri
fungal
parasit
antigen
detect
identif
caus
agent
mani
infecti
diseas
coon
associ
first
use
specif
antibodi
detect
microbi
antigen
detect
pneumococc
antigen
tissu
advantag
ihc
convent
stain
method
tabl
contribut
ihc
infecti
diseas
tabl
substanti
mani
instanc
ihc
shown
high
specif
allow
differenti
morpholog
similar
microorgan
immunohistochemistri
especi
use
microorgan
difficult
identifi
routin
special
stain
fastidi
grow
exhibit
atyp
morpholog
tabl
import
understand
may
widespread
occurr
common
antigen
among
bacteria
pathogen
fungi
monoclon
polyclon
antibodi
must
test
possibl
crossreact
organ
final
import
emphas
ihc
sever
step
affect
final
result
howev
gener
limit
avail
specif
antibodi
preserv
epitop
tabl
list
commerci
avail
antibodi
diagnost
use
surgic
patholog
immunohistochemistri
play
import
role
diagnosi
larg
number
viral
infect
also
studi
pathogenesi
epidemiolog
convent
diagnosi
viral
infect
reli
cytopath
chang
observ
routin
histopatholog
examin
sever
viral
pathogen
produc
characterist
intracellular
inclus
allow
pathologist
make
presumpt
diagnosi
viral
infect
howev
viral
infect
characterist
cytopath
chang
subtl
spars
requir
meticul
search
moreov
known
viral
diseas
associ
characterist
intracellular
inclus
addit
formalin
commonli
use
fix
histopatholog
poor
fix
demonstr
morpholog
tinctori
featur
viral
inclus
viral
inclus
detect
hematoxylin
eosinstain
section
viral
inclus
present
differenti
viral
diseas
immunohistochem
techniqu
offer
reliabl
approach
reach
specif
diagnosi
hepat
b
viru
infect
constitut
import
caus
chronic
hepat
signific
proport
patient
mani
instanc
morpholog
chang
induc
hepat
b
viru
hepatocyt
typic
enough
render
presumpt
diagnosi
hepat
b
viral
infect
instanc
may
littl
hepat
b
surfac
antigen
hbsag
demonstr
techniqu
orcein
stain
case
immunohistochem
techniqu
detect
hbsag
sensit
histochem
method
help
reach
diagnosi
immunostain
hbsag
use
diagnosi
hepat
b
studi
carrier
state
eighti
percent
case
posit
serolog
result
hbsag
demonstr
cytoplasm
hbsag
use
ihc
immunoperoxidas
local
hepat
b
core
antigen
hbcag
demonstr
within
nuclei
cytoplasm
hepatocyt
cytoplasm
express
hbcag
usual
associ
higher
grade
hepat
activ
diffus
immunostain
nuclei
hbcag
gener
suggest
uncontrol
viral
replic
set
immunosuppress
immunostain
hbsag
hbcag
use
diagnosi
recurr
hepat
b
infect
liver
allograft
particularli
present
atyp
histopatholog
featur
histolog
diagnosi
herp
simplex
viru
hsv
infect
involv
detect
multinucl
giant
cell
contain
characterist
mold
ground
glassappear
nuclei
cowdri
type
intranuclear
inclus
abund
viral
inclus
exist
within
infect
cell
diagnosi
usual
straightforward
howev
diagnosi
difficult
characterist
intranuclear
inclus
multinucl
cell
absent
amount
tissu
biopsi
specimen
small
case
ihc
use
either
polyclon
monoclon
antibodi
hsv
antigen
proven
sensit
specif
techniqu
use
diagnos
hsv
infect
fig
although
polyclon
antibodi
major
hsv
glycoprotein
antigen
sensit
allow
distinct
two
virus
antigen
similar
addit
histolog
featur
hsv
infect
specif
also
occur
patient
varicellazost
vzv
infect
monoclon
antibodi
vzv
envelop
glycoprotein
suffici
sensit
specif
allow
clearcut
distinct
hsv
vzv
infect
immunohistochemistri
also
use
demonstr
associ
human
herp
viru
kaposi
sarcoma
primari
effus
lymphoma
multicentr
castleman
diseas
diagnosi
kaposi
sarcoma
may
problemat
broad
morpholog
spectrum
similar
appear
benign
malign
neoplast
vascular
lesion
immunostain
latent
associ
nuclear
use
confirm
diagnosi
kaposi
sarcoma
particularli
difficult
earli
lesion
close
resembl
appear
interstiti
granuloma
annular
neoplasm
present
unusu
locat
immunostain
also
allow
distinct
kaposi
sarcoma
sever
morpholog
similar
vasoprolif
lesion
immunostain
restrict
nuclei
spindl
cell
endotheli
cell
slitlik
vascular
space
fig
immunohistochemistri
also
demonstr
express
mesotheli
cell
hivassoci
recurr
pleural
effus
cytomegaloviru
cmv
continu
import
opportunist
pathogen
immunocompromis
patient
estim
transplant
recipi
experi
cmv
diseas
rang
organ
involv
posttranspl
cmv
diseas
wide
hepat
occur
liver
transplant
recipi
pneumon
frequent
seen
heart
heartlung
transplant
patient
organ
commonli
affect
gastrointestin
tract
peripher
central
nervou
system
histolog
diagnosi
cmv
fix
tissu
usual
rest
identifi
characterist
cytopath
effect
includ
intranuclear
inclus
cytoplasm
inclus
howev
histolog
examin
lack
sensit
addit
patient
gastrointestin
cmv
diseas
fail
demonstr
inclus
case
ihc
use
monoclon
antibodi
earli
late
cmv
antigen
allow
detect
cmv
antigen
nucleu
cytoplasm
infect
cell
fig
sensit
ihc
detect
cmv
infect
rang
addit
ihc
may
allow
detect
cmv
antigen
earli
cours
diseas
cytopath
chang
yet
develop
exampl
cmv
earli
nuclear
antigen
express
hour
cellular
infect
indic
earli
activ
viral
replic
immunohistochemistri
use
detect
cmv
infect
patient
steroid
refractori
ulcer
coliti
routin
use
ihc
detect
cmv
evalu
patient
recommend
cmv
immunostain
use
detect
occult
cmv
infect
central
nervou
system
liver
transplant
patient
develop
neurolog
complic
also
use
demonstr
high
frequenc
cmv
antigen
tissu
firsttrimest
abort
cmv
common
opportunist
organ
found
liver
biopsi
transplant
patient
nonetheless
incid
cmv
hepat
appear
decreas
owe
better
prophylact
treatment
although
cmv
hepat
present
characterist
neutrophil
aggreg
within
liver
parenchyma
atyp
featur
suggest
acut
reject
chang
indistinguish
viral
hepat
occasion
observ
addit
parenchym
neutrophil
microabscess
describ
case
evid
cmv
infect
case
immunostain
cmv
antigen
use
determin
diagnosi
cmv
infect
sensit
ihc
better
light
microscop
identif
viral
inclus
compar
favor
cultur
situ
hybrid
addit
immunohistochem
assay
complet
faster
shell
vial
cultur
techniqu
allow
rapid
result
import
earli
anticmv
therapi
herpesviru
infect
diagnos
use
immunohistochem
method
includ
human
herpesviru
infect
epsteinbarr
viral
infect
immunohistochemistri
use
identifi
ebv
latent
membran
case
hodgkin
lymphoma
posttranspl
lymphoprolif
disord
fig
adenoviru
increasingli
recogn
caus
morbid
mortal
among
immunocompromis
patient
owe
transplant
congenit
immunodefici
rare
adenoviru
infect
describ
hivinfect
patient
characterist
adenoviru
inclus
amphophil
intranuclear
homogen
glassi
howev
case
infect
may
contain
rare
cell
show
characterist
cytopath
effect
addit
viral
inclus
includ
cmv
human
papillomaviru
hpv
hsv
vzv
mistaken
adenoviru
inclus
vice
versa
circumst
immunohistochem
assay
may
necessari
definit
diagnosi
monoclon
antibodi
reactiv
serotyp
adenoviru
use
immunohistochem
techniqu
demonstr
intranuclear
adenovir
antigen
immunocompromis
patient
fig
histolog
diagnosi
adenoviru
coliti
difficult
usual
underdiagnos
moreov
immunosuppress
patient
incid
coinfect
virus
high
presenc
adenoviru
tend
overlook
immunohistochem
stain
valu
differenti
adenoviru
coliti
cmv
coliti
parvoviru
associ
asymptomat
infect
erythema
infectiosum
acut
arthropathi
aplast
crisi
hydrop
fetali
chronic
anemia
red
cell
aplasia
addit
parvoviru
infect
recogn
import
caus
sever
anemia
immunocompromis
leukem
patient
receiv
chemotherapi
diagnosi
parvoviru
infect
achiev
identifi
typic
find
bone
marrow
specimen
includ
decreas
absent
red
cell
precursor
giant
pronormoblast
eosinophil
amphophil
intranuclear
inclus
erythroid
cell
intraven
immunoglobulin
therapi
effect
rapid
accur
diagnost
method
import
immunohistochemistri
monoclon
antibodi
capsid
protein
use
rapid
sensit
method
establish
diagnosi
parvoviru
infect
formalinfix
paraffinembed
tissu
immunohistochemistri
particular
help
detect
parvoviru
antigen
case
spars
inclus
studi
case
initi
identifi
examin
routin
stain
tissu
section
case
hydrop
fetali
advanc
cytolysi
fig
sever
studi
found
strong
correl
among
result
obtain
morpholog
immunohistochem
situ
hybrid
ish
polymeras
chain
reaction
pcr
method
sinc
numer
emerg
reemerg
agent
viral
hemorrhag
fever
attract
attent
pathologist
investig
play
import
role
identifi
agent
support
epidemiolog
clinic
pathogenet
studi
emerg
viral
hemorrhag
fever
viral
hemorrhag
fever
often
fatal
clinic
difficult
diagnos
absenc
bleed
organ
manifest
frequent
requir
handl
test
potenti
danger
biolog
specimen
addit
histopatholog
featur
pathognomon
resembl
viral
rickettsi
bacteri
eg
leptospirosi
infect
immunohistochemistri
essenti
success
safe
appli
diagnosi
studi
pathogenesi
diseas
sever
studi
establish
util
ihc
sensit
safe
rapid
diagnost
method
diagnosi
viral
hemorrhag
fever
yellow
fever
fig
dengu
hemorrhag
fever
crimeancongo
hemorrhag
fever
argentin
hemorrhag
fever
venezuelan
hemorrhag
fever
marburg
diseas
addit
sensit
specif
safe
immunostain
method
develop
diagnos
ebola
hemorrhag
fever
formalinfix
skin
biopsi
fig
immunohistochemistri
demonstr
lassa
viru
target
primarili
endotheli
cell
mononuclear
inflammatori
cell
hepatocyt
fig
polyomavirus
bk
viru
infect
frequent
infanc
immunocompet
individu
viru
remain
latent
kidney
central
nervou
system
b
lymphocyt
immunocompromis
patient
infect
reactiv
spread
organ
bk
viru
nephropathi
import
caus
graft
failur
patient
renal
transplant
preval
vari
differ
transplant
center
sinc
specif
clinic
sign
symptom
lack
bk
viru
nephropathi
diagnosi
made
histolog
graft
biopsi
kidney
infect
associ
mononuclear
interstiti
inflammatori
infiltr
tubular
atrophi
find
difficult
distinguish
acut
reject
cytopath
chang
observ
bk
viru
infect
pathognomon
observ
viral
infect
moreov
earli
bk
viru
infect
minim
histolog
chang
although
ihc
identifi
viral
antigen
set
ihc
antibodi
larg
antigen
viru
effect
demonstr
bk
viru
infect
fig
human
polyomaviru
jc
doublestrand
dna
viru
caus
progress
multifoc
leukoencephalopathi
pml
fatal
demyelin
diseas
character
cytopath
chang
oligodendrocyt
bizarr
giant
astrocyt
addit
detect
antibodi
antigen
ihc
use
polyclon
rabbit
antiserum
protein
specif
sensit
rapid
method
use
confirm
diagnosi
pml
jc
viru
antigen
usual
seen
within
oligodendrocyt
fig
occasion
astrocyt
antigenbear
cell
commonli
seen
earli
lesion
immunohistochemistri
also
use
confirm
diagnosi
respiratori
viral
diseas
influenza
viru
respiratori
syncyti
viru
infect
fig
cultur
avail
diagnosi
rabi
reli
heavili
histopatholog
examin
tissu
demonstr
characterist
cytoplasm
inclus
negri
bodi
signific
percentag
case
negri
bodi
inconspicu
confirm
diagnosi
rabi
extrem
difficult
furthermor
nonendem
area
diagnosi
rabi
usual
suspect
clinic
patient
may
present
ascend
paralysi
set
immunohistochem
stain
sensit
specif
safe
diagnost
tool
rabi
fig
viral
agent
diagnos
use
immunohistochem
method
includ
enterovirus
eastern
equin
enceph
viru
rotaviru
immunohistochem
stain
use
histopatholog
diagnosi
viral
hepat
c
howev
ihc
viru
effect
serolog
assay
detect
hcv
rna
serum
among
bacteri
infect
greatest
number
immunohistochem
studi
perform
investig
helicobact
pylori
studi
evalu
use
ihc
bacteri
mycobacteri
rickettsi
spirochet
infect
antigen
retriev
gener
requir
immunohistochem
demonstr
bacteria
fix
tissu
howev
interpret
result
complic
mani
antibodi
crossreact
bacteria
moreov
antibodi
may
react
portion
bacteria
may
label
remnant
bacteria
spirochet
viabl
organ
longer
present
gastric
infect
h
pylori
result
chronic
activ
gastriti
strongli
associ
lymphoid
hyperplasia
gastric
lymphoma
gastric
adenocarcinoma
heavi
infect
numer
organ
easili
detect
routin
hematoxylin
eosinstain
tissu
howev
detect
rate
mani
falseposit
falseneg
result
convent
histochem
method
silver
stain
sensit
hematoxylin
eosin
detect
h
pylori
nonetheless
detect
scant
number
organ
proven
ihc
high
specif
sensit
less
expens
factor
consid
superior
convent
histochem
method
low
interobserv
variat
fig
treatment
chronic
activ
gastriti
h
pylori
infect
chang
shape
microorgan
make
difficult
identifi
differenti
organ
extracellular
debri
mucin
globul
case
ihc
improv
rate
success
identif
bacteria
even
histolog
examin
cultur
fals
neg
whippl
diseas
affect
primarili
small
bowel
mesenter
lymph
node
less
commonli
organ
heart
central
nervou
system
numer
foami
macrophag
character
diseas
diagnosi
usual
reli
demonstr
pasposit
intracytoplasm
bacteria
nevertheless
presenc
pasposit
macrophag
pathognomon
observ
diseas
mycobacterium
avium
infect
histoplasmosi
rhodococcu
equi
infect
macroglobulinemia
tropheryma
whipplei
rare
caus
endocard
share
mani
histolog
featur
cultureneg
endocarditid
caus
coxiella
burnetii
bartonella
sp
develop
specif
antibodi
microorgan
significantli
enhanc
abil
detect
heart
valv
patient
cultureneg
endocard
immunohistochem
stain
rabbit
polyclon
antibodi
provid
sensit
specif
method
rapid
diagnosi
intestin
extraintestin
whippl
diseas
followup
treatment
respons
confirm
rocki
mountain
spot
fever
rmsf
usual
requir
use
serolog
method
detect
antibodi
spot
fever
group
sfg
rickettsia
howev
patient
rmsf
lack
diagnost
titer
first
week
diseas
immunohistochemistri
success
use
detect
sfg
rickettsia
formalinfix
tissu
section
superior
histochem
method
fig
sever
studi
illustr
valu
ihc
diagnos
suspect
case
rmsf
use
skin
biopsi
high
specif
sensit
confirm
fatal
case
seroneg
rmsf
r
rickettsii
distinguish
spot
fever
group
rickettsia
r
parkeri
r
conorii
crossreact
bartonella
slowgrow
fastidi
gramneg
warthinstarrystain
bacteria
associ
bacillari
angiomatosi
peliosi
hepati
catscratch
diseas
trench
fever
relaps
bacteremia
dissemin
granulomat
lesion
liver
spleen
bartonella
import
agent
blood
cultureneg
endocard
tradit
techniqu
histolog
electron
microscopi
serolog
employ
identifi
agent
cultureneg
endocard
howev
bartonella
sp
c
burnetii
whipplei
endocard
share
mani
morpholog
featur
allow
specif
histolog
diagnosi
besid
serolog
test
bartonella
sp
may
show
crossreact
c
burnetii
chlamydia
sp
immunostain
success
use
identifi
bartonella
hensela
b
quintana
heart
valv
patient
blood
cultureneg
endocard
significantli
enhanc
abil
establish
specif
diagnosi
case
polyclon
rabbit
antibodi
differenti
b
hensela
b
quintana
also
use
detect
microorgan
catscratch
diseas
fig
bacillari
angiomatosi
peliosi
hepati
commerci
avail
monoclon
antibodi
specif
b
hensela
also
avail
use
demonstr
organ
case
spontan
splenic
ruptur
caus
bacterium
syphili
continu
public
health
problem
caus
pallidum
fastidi
organ
cultiv
diagnosi
syphili
reli
serolog
identif
pallidum
darkfield
microscopi
howev
method
low
sensit
specif
serolog
method
neg
earli
stage
diseas
immunosuppress
patient
coinfect
human
immunodefici
viru
hiv
tissu
section
usual
method
detect
spirochet
silver
impregn
stain
warthinstarri
steiner
stain
howev
technic
difficult
perform
interpret
nonspecif
frequent
show
mark
background
artifact
silver
stain
also
highlight
melanin
granul
reticulin
fiber
detect
rate
spirochet
use
silver
stain
vari
shown
immunostain
biopsi
specimen
antit
pallidum
polyclon
antibodi
fig
sensit
specif
silver
stain
method
sensit
rang
identif
tuberculosi
routin
achiev
acidfast
bacilli
afb
stain
cultur
biopsi
specimen
nevertheless
afb
stain
low
sensit
specif
differenti
mycobacteri
speci
furthermor
cultur
may
take
sever
week
sensit
low
paucibacillari
lesion
histolog
diagnosi
mycobacteri
infect
ihc
antibcg
polyclon
antibodi
shown
better
sensit
afb
stain
howev
paucibacillari
lesion
inferior
afb
stain
differenti
tuberculosi
mycobacteria
recent
polyclon
antibodi
tuberculosissecret
antigen
use
case
mycobacteri
lymphaden
method
show
sensit
specif
perform
better
afb
stain
case
paucibacillari
diseas
compar
nest
pcr
bacteri
diseas
identifi
ihc
formalinfix
tissu
includ
leptospirosi
zoonosi
usual
present
acut
febril
syndrom
occasion
unusu
manifest
pulmonari
hemorrhag
respiratori
failur
abdomin
pain
rabbit
polyclon
antibodi
use
ihc
detect
leptospir
antigen
gallbladd
lung
patient
unusu
present
fig
lyme
diseas
protean
clinic
manifest
borrelia
burgdoferi
difficult
cultur
tissu
fluid
addit
cultur
rare
posit
week
incub
borrelia
burgdorferi
identifi
tissu
immunostain
polyclon
monoclon
antibodi
although
ihc
specif
silver
impregn
stain
sensit
immunostain
poor
microorgan
difficult
detect
owe
low
number
present
tissu
section
q
fever
zoonosi
caus
coxiella
burnetii
character
protean
nonspecif
manifest
acut
q
fever
manifest
atyp
pneumonia
granulomat
hepat
frequent
characterist
fibrin
ring
granuloma
microorgan
recogn
one
agent
caus
blood
cultureneg
chronic
endocard
monoclon
antibodi
use
specif
identifi
c
burnetii
cardiac
valv
patient
chronic
q
fever
endocard
recent
ihc
success
use
identifi
streptococcu
pneumonia
formalinfix
organ
overal
sensit
specif
compar
cultur
immunohistochem
assay
use
identifi
clostridium
sp
aureu
pyogen
haemophilu
influenza
chlamydia
speci
legionella
pneumophila
l
dumoffii
listeria
monocytogen
salmonella
rickettsi
infect
rocki
mountain
spot
fever
boutonneus
fever
epidem
typhu
murin
typhu
rickettsialpox
african
tick
bite
fever
scrub
typhu
great
major
fungi
readili
identifi
hematoxylin
eosin
stain
alon
combin
histochem
stain
eg
period
acidschiff
pa
gomori
methenamin
silver
gm
howev
stain
distinguish
morpholog
similar
fungi
potenti
differ
suscept
antimycot
drug
addit
sever
factor
may
influenc
appear
fungal
element
may
appear
atyp
tissu
section
steric
orient
age
fungal
lesion
effect
antifung
chemotherapi
type
infect
tissu
host
immun
respons
current
final
identif
fungi
reli
cultur
techniqu
howev
cultur
may
take
sever
day
longer
yield
definit
result
surgic
pathologist
rare
access
fresh
tissu
past
year
ihc
use
identifi
variou
fungal
element
paraffinembed
formalinfix
tissu
immunohistochem
method
advantag
provid
rapid
specif
identif
sever
fungi
allow
pathologist
identifi
unusu
filament
hyphal
yeast
infect
accur
distinguish
confound
artifact
addit
ihc
allow
pathologist
correl
microbiolog
histolog
find
fungal
infect
distinguish
harmless
colon
immunohistochemistri
also
help
one
fungu
present
case
dual
immunostain
techniqu
highlight
differ
fungal
speci
present
tissu
import
limit
ihc
identif
fungi
wellknown
widespread
occurr
common
antigen
among
pathogen
fungi
frequent
result
crossreact
polyclon
antibodi
even
monoclon
antibodi
therefor
assess
crossreact
use
panel
fungi
import
step
evalu
immunohistochem
method
candida
speci
often
stain
weakli
hematoxylin
eosin
sometim
yeast
form
may
difficult
differenti
histoplasma
capsulatum
cryptococcu
neoforman
even
pneumocysti
carinii
polyclon
monoclon
antibodi
candida
genu
antigen
sensit
strongli
reactiv
show
crossreact
fungi
test
particular
two
monoclon
antibodi
candida
albican
mannoprotein
show
high
sensit
specif
monoclon
antibodi
recogn
primarili
filament
form
c
albican
wherea
monoclon
antibodi
highlight
yeast
form
identif
cryptococcu
neoforman
usual
problem
fungu
produc
mucicarmineposit
capsul
howev
infect
capsuleneg
strain
difficult
diagnos
diseas
confus
histoplasmosi
blastomycosi
torulopsi
also
longstand
infect
yeast
often
appear
atyp
fragment
polyclon
antibodi
rais
c
neoforman
yeast
cell
sensit
specif
recent
monoclon
antibodi
produc
allow
identif
differenti
varieti
c
neoforman
formalinfix
tissu
antibodi
highli
sensit
specif
differenti
c
neoforman
var
neoforman
c
neoforman
var
gattii
sporothrix
schenckii
may
confus
tissu
section
blastomyc
dermatitidi
fungal
agent
phaeohyphomycosi
addit
yeast
cell
sporothrix
schenckii
may
spars
present
tissu
antibodi
yeast
cell
schenckii
sensit
demonstr
crossreact
candida
speci
howev
specif
adsorpt
antibodi
candida
yeast
cell
crossreact
antibodi
elimin
invas
aspergillosi
frequent
caus
fungal
infect
high
morbid
mortal
rate
immunocompromis
patient
diagnosi
often
difficult
reli
heavili
histolog
identif
invas
septat
hypha
cultur
confirm
nevertheless
sever
filament
fungi
fusarium
speci
pseudallescheria
boydii
scedosporium
speci
share
similar
morpholog
aspergillu
speci
hematoxylin
eosinstain
tissu
precis
rapid
diagnosi
invas
aspergillosi
import
earli
diagnosi
associ
improv
clinic
respons
allow
plan
correct
durat
choic
antimycot
therapi
research
shown
yield
cultur
histolog
proven
case
low
rang
sever
polyclon
monoclon
antibodi
aspergillu
antigen
test
formalinfix
tissu
variabl
sensit
crossreact
fungi
recent
monoclon
antibodi
aspergillu
galactomannan
shown
high
sensit
specif
identifi
fumigatu
flavu
niger
formalinfix
tissu
without
crossreact
filament
fungi
cyst
trophozoit
pneumocysti
jirovecii
detect
bronchoalveolar
lavag
specimen
use
monoclon
antibodi
yield
result
slightli
sensit
gm
giemsa
papanicola
stain
fig
antibodi
help
case
extrapulmonari
pneumocystosi
diagnosi
p
jirovecii
pneumonia
atyp
patholog
featur
present
eg
hyalin
membran
granulomat
pneumocystosi
microorgan
usual
spars
penicillium
marneffei
caus
dissemin
infect
immunocompromis
patient
morpholog
organ
must
differenti
h
capsulatum
c
neoforman
c
albican
monoclon
antibodi
galactomannan
aspergillu
speci
crossreact
detect
p
marneffei
tissu
section
immunohistochemistri
also
use
detect
blastomyc
coccidioid
histoplasma
howev
antibodi
signific
crossreact
sever
fungi
protozoa
usual
identifi
tissu
section
stain
hematoxylin
eosin
giemsa
stain
howev
small
size
organ
subtl
distinguish
featur
unequivoc
diagnosi
alway
made
role
ihc
detect
protozo
infect
particularli
valuabl
case
morpholog
parasit
distort
tissu
necrosi
autolysi
addit
immunocompromis
patient
toxoplasmosi
unusu
dissemin
present
numer
tachyzoit
without
bradyzoit
fig
immunohistochemistri
also
use
case
unusu
present
diseas
diagnosi
leishmaniasi
routin
practic
usual
difficult
howev
certain
circumst
patholog
diagnosi
may
problemat
case
chronic
granulomat
leishmaniasi
small
number
parasit
microorgan
present
unusu
locat
necrosi
distort
morpholog
appear
diseas
case
immunohistochem
stain
valuabl
diagnost
tool
highli
sensit
specif
monoclon
antibodi
recogn
differ
speci
leishmania
allow
differenti
morpholog
similar
microorgan
toxoplasma
trypanosoma
cruzi
p
marneffei
immunohistochem
assay
use
polyclon
antibodi
specif
balamuthia
mandrillari
naegleria
fowleri
acanthamoeba
sp
use
demonstr
ameb
trophozoit
cyst
area
necrosi
allow
differenti
macrophag
case
ameb
meningoenceph
immunohistochemistri
also
use
identifi
cryptosporidium
entamoeba
histolytica
trypanosoma
cruzi
babesia
giardia
lamblia
plasmodium
falciparum
p
vivax
fatal
case
malaria
formalinfix
paraffinembed
tissu
sampl
institut
medicin
defin
emerg
infecti
diseas
eid
caus
new
previous
unidentifi
microorgan
whose
incid
human
increas
within
previou
two
decad
threaten
increas
near
futur
list
pathogen
newli
recogn
sinc
long
continu
increas
recogn
emerg
infect
challeng
mani
new
infecti
agent
remain
undetect
year
emerg
identifi
public
health
problem
eid
global
phenomenon
requir
global
respons
center
diseas
control
prevent
cdc
defin
strategi
prevent
detect
eid
anatom
patholog
laboratori
play
critic
role
initi
rapid
detect
eid
besid
assist
identif
new
infecti
agent
ihc
contribut
understand
pathogenesi
epidemiolog
eid
southwestern
unit
state
sever
previous
healthi
individu
die
rapidli
progress
pulmonari
edema
respiratori
insuffici
shock
immunohistochemistri
play
central
role
identifi
viral
antigen
unknown
hantaviru
detect
occurr
unrecogn
case
hantaviru
pulmonari
syndrom
prior
show
distribut
viral
antigen
endotheli
cell
microcircul
particularli
lung
fig
west
nile
viru
wnv
origin
identifi
africa
first
case
wnv
enceph
unit
state
describ
clinic
pictur
variabl
nonspecif
rang
subclin
infect
flaccid
paralysi
enceph
character
morpholog
perivascular
mononuclear
cell
inflammatori
infiltr
neuron
necrosi
edema
microgli
nodul
particularli
promin
brainstem
cerebellum
spinal
cord
diagnosi
wnv
enceph
usual
establish
identifi
virusspecif
igm
csf
andor
serum
demonstr
viral
rna
serum
csf
tissu
immunostain
monoclon
polyclon
antibodi
success
use
diagnos
wnv
infect
immunocompromis
patient
inadequ
antibodi
respons
fig
enteroviru
associ
hand
foot
mouth
diseas
herpangina
asept
mening
poliomyelitislik
flaccid
paralysi
recent
associ
unusu
case
fulmin
enceph
pulmonari
edema
hemorrhag
heart
failur
sever
extens
encephalomyel
cerebr
cortex
brainstem
spinal
cord
describ
immunohistochem
stain
monoclon
antibodi
play
pivot
role
link
infect
fulmin
enceph
fig
viral
antigen
observ
within
neuron
neuron
process
mononuclear
inflammatori
cell
nipah
viru
recent
describ
paramyxoviru
caus
acut
febril
encephalit
syndrom
high
mortal
rate
patholog
play
key
role
identifi
caus
agent
histopatholog
find
includ
vascul
thrombosi
microinfarct
syncyti
giant
cell
viral
inclus
although
characterist
diseas
syncyti
giant
endotheli
cell
seen
case
viral
inclus
similar
morpholog
seen
paramyxovir
infect
immunostain
provid
use
tool
unequivoc
diagnosi
diseas
demonstr
viral
antigen
within
neuron
endotheli
cell
organ
fig
ehrlichios
ticktransmit
intracellular
gramneg
bacteria
belong
genera
ehrlichia
anaplasma
agent
human
monocytotrop
ehrlichiosi
human
granulocytotrop
anaplasmosi
respect
acut
febril
ill
usual
present
cytopenia
myalgia
mild
moder
hepat
diagnosi
ehrlichiosi
depend
upon
find
characterist
monocyt
andor
granulocyt
cytoplasm
inclus
morula
pcr
analysi
blood
detect
specif
antibodi
blood
howev
morula
rare
often
miss
initi
evalu
hematoxylin
eosinstain
section
often
fail
show
organ
even
ihc
reveal
abund
ehrlichi
antigen
antibodi
titer
may
take
sever
week
rise
diagnost
level
addit
immunocompromis
patient
may
develop
antiehrlichi
antibodi
prior
death
case
immunostain
ehrlichia
anaplasma
sensit
specif
diagnost
method
immunohistochemistri
valuabl
tool
use
identifi
studi
sever
eid
ebola
hemorrhag
fever
hendra
viru
enceph
leptospirosi
emerg
tickborn
rickettsios
r
parkeri
r
africa
recent
new
coronaviru
associ
sever
acut
respiratori
syndrom
sar
sar
first
recogn
global
outbreak
sever
pneumonia
occur
late
guangdong
provinc
china
erupt
februari
case
two
dozen
countri
asia
europ
north
america
south
america
earli
investig
clinic
patholog
laboratori
studi
focus
previous
known
agent
respiratori
ill
subsequ
viru
isol
oropharynx
sar
patient
identifi
ultrastructur
characterist
belong
famili
coronavirida
variou
report
describ
diffus
alveolar
damag
main
histopatholog
find
sar
patient
sarsassoci
coronaviru
sarscov
demonstr
human
experiment
anim
tissu
immunohistochem
fig
ish
assay
increas
concern
use
infecti
agent
potenti
biolog
weapon
biolog
warfar
agent
vari
rare
exot
virus
common
bacteri
agent
intent
use
biolog
agent
caus
diseas
simul
natur
occur
outbreak
may
unusu
characterist
cdc
issu
recommend
complet
public
health
respons
biolog
attack
two
import
compon
respons
plan
includ
rapid
diagnosi
character
biolog
agent
pathologist
use
newer
diagnost
techniqu
ihc
ish
pcr
direct
impact
pathologist
immunohistochemistri
bioterror
rapid
detect
control
emerg
infecti
diseas
natur
intent
caus
immunohistochemistri
provid
simpl
safe
sensit
specif
method
rapid
detect
biolog
threat
time
investig
retrospect
therebi
facilit
rapid
implement
effect
public
health
respons
immunohistochem
stain
bacillu
anthraci
monoclon
antibodi
cell
wall
capsul
antigen
success
use
recognit
bioterrorismrel
anthrax
case
import
step
earli
diagnosi
treatment
fig
gram
stain
cultur
isol
b
anthraci
usual
use
diagnos
anthrax
howev
previou
antibiot
treatment
affect
cultur
yield
gram
stain
identif
bacteria
immunohistochemistri
demonstr
high
sensit
specif
detect
b
anthraci
skin
biopsi
pleural
biopsi
transbronchi
biopsi
pleural
fluid
see
fig
addit
immunostain
use
determin
rout
entri
bacteria
identifi
mode
spread
diseas
tularemia
immunohistochem
stain
also
valuabl
rapid
identif
francisella
tularensi
formalinfix
tissu
section
tularemia
variabl
clinic
patholog
present
simul
infecti
diseas
anthrax
plagu
catscratch
diseas
lymphogranuloma
venereum
moreov
microorgan
difficult
demonstr
tissu
section
even
gram
stain
silver
stain
method
mous
monoclon
antibodi
lipopolysaccharid
f
tularensi
use
high
sensit
specif
demonstr
intact
bacteria
granular
bacteri
antigen
lung
spleen
lymph
node
liver
fig
plagu
mous
monoclon
antibodi
direct
fraction
antigen
yersinia
pesti
use
detect
intracellular
extracellular
bacteria
dermal
blood
vessel
lung
lymph
node
spleen
liver
fig
techniqu
potenti
use
rapid
diagnosi
plagu
formalinfix
skin
biopsi
addit
ihc
differenti
primari
secondari
pneumon
plagu
identifi
pesti
differ
lung
locat
eg
alveoli
vs
interstitium
immunohistochem
method
use
polyclon
monoclon
antibodi
use
identifi
sever
potenti
biolog
terror
agent
includ
caus
agent
brucellosi
q
fever
sinc
enorm
advanc
molecular
technolog
dramat
influenc
diagnosi
studi
infecti
diseas
applic
molecular
probe
studi
diagnosi
infecti
diseas
great
adjunct
ihc
diagnost
method
often
allow
even
rapid
specif
identif
organ
along
rapid
advanc
molecular
diagnost
techniqu
increas
interest
use
paraffinembed
specimen
nucleic
acid
hybrid
assay
two
main
hybrid
format
use
diagnost
patholog
laboratori
diagnosi
infecti
diseas
ish
pcr
situ
hybrid
analog
ihc
allow
cellular
identif
local
microbi
pathogen
instead
microbi
antigen
target
ish
specif
rna
dna
sequenc
mani
virus
fig
bacteria
fig
microorgan
local
tissu
ish
includ
epsteinbarr
viru
hpv
fig
polyomavirus
fig
mycobacterium
lepra
legionella
haemophilu
influenza
zygomycet
aspergillu
pcr
advantag
increas
sensit
minim
tissu
requir
potenti
sequenc
amplifi
product
specif
identif
microbi
genotyp
strain
agent
involv
pcr
assay
microorgan
adapt
use
formalinfix
tissu
summari
ihc
ish
pcr
regard
complementari
diagnost
method
use
diagnost
patholog
laboratori
laboratori
must
consid
advantag
limit
method
appli
case
common
need
laboratori
everexpand
field
behoov
pathologist
interest
field
infecti
diseas
keep
abreast
chang
technolog
everincreas
applic
arena
diagnosi
